Ocular pharmacologists have developed various pharmaceutical agents with applications in the treatment of glaucoma by recognizing the potential to lower intraocular pressure by manipulating adrenergic receptors. This article discusses the therapeutic use and effects of adrenergic agents in glaucoma therapy, including α-2 agonist, brimonidine, β-blockers, timolol, betaxolol, carteolol, levobunolol, and metipranolol.
|Original language||English (US)|
|Number of pages||17|
|Journal||Ophthalmology Clinics of North America|
|State||Published - Oct 29 1997|
ASJC Scopus subject areas